Differences

This shows you the differences between two versions of the page.

--- supplements:start [2026/02/14 18:54] – [High-Risk Supplements (Clinically Important)] andrew2393cns
+++ supplements:start [2026/02/14 18:57] (current) – [4) Pain / Inflammation] andrew2393cns
@@ Line 40: / Line 40: @@
   * [[endocrine:tzds:start|TZDs]] (e.g., [[endocrine:tzds:pioglitazone|Pioglitazone]])
   * [[endocrine:insulin:start|Insulin]]
-  * [[endocrine:glp1_gip_gra:glp1:start|GLP-1 Receptor Agonists]] (e.g., [[endocrine:glp1_gip_gra:glp1:semaglutide|Semaglutide]], [[endocrine:glp1_gip_gra:glp1:liraglutide|Liraglutide]])
+  * [[endocrine:glp1:start|GLP-1 Receptor Agonists]] (e.g., [[endocrine:glp1:semaglutide|Semaglutide]], [[endocrine:glp1:liraglutide|Liraglutide]])
-  * [[endocrine:glp1_gip:dual_glp-1_gip_incretin_agonists|Dual GLP-1/GIP Agonists]] (e.g., [[endocrine:glp1_gip_gra:incretin:tirzepatide|Tirzepatide]])
+  * [[endocrine:glp1_gip:dual_glp-1_gip_incretin_agonists|Dual GLP-1/GIP Agonists]] (e.g., [[endocrine:incretin:tirzepatide|Tirzepatide]])
 Common supplements:
@@ Line 105: / Line 105: @@
 Common supplements:
+  * [[supplements:kratom|Kratom]]
   * [[supplements:turmeric_curcumin|Turmeric / curcumin]]
   * [[supplements:omega_3_fatty_acids|Omega-3 fatty acids]]